Interesting Engineering on MSN19h
Gold-based drug slows cancer tumor growth by 82%, outperforms chemotherapyA new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.
Chemotherapy drugs can kill cancer cells by halting DNA replication, but a glucose-depleted environment can help cancer cells ...
Princess Kate Middleton will be joining husband Prince William and other members of the royal family for an upcoming state ...
GlobalData on MSN23h
BeiGene’s PD-1 drug approved in EU for first-line oesophageal cancer treatmentThe European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...
News Medical on MSN2d
Study details how cancer cells fend off starvation and death from chemotherapyLaboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows.
In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...
Glioblastoma typically kills within 18 months, but a new type of treatment has kept Nadya El-Afandi's scans clear 17 months ...
Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new study.
Nina Wilson gave thanks at the end of her four-hour chemotherapy session this week. Thanks to the efforts of fellow cancer ...
Tragically, many patients present with these cancers at advanced stages and late detection means that despite employing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback